{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-25-000002","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.682410+00:00","generated_at":"2026-05-26T02:55:58.552874+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"USPH Q4 revenue up 14.2% to $180.4M; adjusted EBITDA $21.8M; dividend raised to $0.45","bullets":["Q4 net revenue $180.4M (PT $153.8M + IIP $26.6M), vs $154.8M prior year; full-year revenue $671.3M.","Q4 adjusted EBITDA $21.8M (+14.7% YoY); full-year adjusted EBITDA $81.8M (+5.0% YoY).","Q4 GAAP EPS $0.52 vs ($0.38); non-GAAP operating results $0.51/share vs $0.59.","Dividend raised to $0.45/share from $0.44; payable Apr 11 to holders of record Mar 14.","2025 adjusted EBITDA guidance $88M-$93M; Medicare rate cut to reduce revenue ~$6.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-25-000002","json":"https://secwatch.observer/filing/0000885978-25-000002.json","markdown":"https://secwatch.observer/filing/0000885978-25-000002.md","text":"https://secwatch.observer/filing/0000885978-25-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597825000002/0000885978-25-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597825000002/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:55:58.552874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}